DJIA 17,888.35 168.43 0.95%
NASDAQ 5,156.31 47.64 0.93%
S&P 500 2,102.63 22.22 1.07%
market minute promo

148.72 2.13 (1.45%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

JAZZ $148.72 1.45%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $146.92
Previous Close $146.59
Daily Range $145.27 - $148.89
52-Week Range $117.26 - $194.73
Market Cap $9.1B
P/E Ratio 28.03
Dividend (Yield) $0.00 (0.0%)
Volume 532,857
Average Daily Volume 833,993
Current FY EPS $5.58




Drug Makers

Jazz Pharmaceuticals, Inc. (JAZZ) Description

A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Website:

News & Commentary

3 Companies That Could Become Tax Inversion Targets

The Pfizer-Allergan deal may not be the last tax inversion deal we witness. These three companies could also become the target of a U.S.-based buyer.

Insider Trading Alert - CB, JAZZ And IRT Traded By Insiders

Insider Trading Alert - CIEN, JAZZ And WDFC Traded By Insiders

These Biotech Stocks May Start Paying Dividends in 2016

Despite not being known for their dividends, these biotech stocks could begin paying stipends to shareholders in 2016.

3 Great Stocks on Sale

Sometimes, great stocks can be bought at a discount. Here are three wonderful examples.

Insider Trading Alert - PMC, JAZZ And EA Traded By Insiders

Jazz's Q3 Earnings & Revenues Grow Y/Y; Trims 2015 Outlook

Benzinga's Top Downgrades

Jazz Pharmaceuticals Plc (JAZZ) Bruce C. Cozadd on Q3 2015 Results - Earnings Call Transcript

Jazz Pharmaceuticals (JAZZ) Q3 2015 Results - Earnings Call Webcast

See More JAZZ News...

JAZZ's Top Competitors

JAZZ $148.72 (1.45%)
Current stock: JAZZ
JNJ $102.36 (1.11%)
Current stock: JNJ
PFE $33.62 (2.59%)
Current stock: PFE
NVS $85.95 (0.83%)
Current stock: NVS